These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 34557161)

  • 1. Identification of Key Candidate Genes and Chemical Perturbagens in Diabetic Kidney Disease Using Integrated Bioinformatics Analysis.
    Gao Z; S A; Li XM; Li XL; Sui LN
    Front Endocrinol (Lausanne); 2021; 12():721202. PubMed ID: 34557161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic kidney disease-predisposing proinflammatory and profibrotic genes identified by weighted gene co-expression network analysis (WGCNA).
    Chen J; Luo SF; Yuan X; Wang M; Yu HJ; Zhang Z; Yang YY
    J Cell Biochem; 2022 Feb; 123(2):481-492. PubMed ID: 34908186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the pathogenesis of diabetic kidney disease by microarray data analysis.
    Cao H; Rao X; Jia J; Yan T; Li D
    Front Pharmacol; 2022; 13():932205. PubMed ID: 36059966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of key genes for diabetic kidney disease using biological informatics methods.
    Ma F; Sun T; Wu M; Wang W; Xu Z
    Mol Med Rep; 2017 Dec; 16(6):7931-7938. PubMed ID: 28990106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray analysis reveals gene and microRNA signatures in diabetic kidney disease.
    Cui C; Cui Y; Fu Y; Ma S; Zhang S
    Mol Med Rep; 2018 Feb; 17(2):2161-2168. PubMed ID: 29207157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and construction of lncRNA-associated ceRNA network in diabetic kidney disease.
    Wang Y; Tan J; Xu C; Wu H; Zhang Y; Xiong Y; Yi C
    Medicine (Baltimore); 2021 Jun; 100(22):e26062. PubMed ID: 34087849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening and Identification of Hub Genes in the Development of Early Diabetic Kidney Disease Based on Weighted Gene Co-Expression Network Analysis.
    Wei R; Qiao J; Cui D; Pan Q; Guo L
    Front Endocrinol (Lausanne); 2022; 13():883658. PubMed ID: 35721731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression-based analysis identified NTNG1 and HGF as biomarkers for diabetic kidney disease.
    Tang YL; Dong XY; Zeng ZG; Feng Z
    Medicine (Baltimore); 2020 Jan; 99(1):e18596. PubMed ID: 31895808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Lipotoxicity-Related Biomarkers in Diabetic Nephropathy Based on Bioinformatic Analysis.
    Nie H; Yang H; Cheng L; Yu J
    J Diabetes Res; 2024; 2024():5550812. PubMed ID: 38774257
    [No Abstract]   [Full Text] [Related]  

  • 10. Identification of Novel Key Molecular Signatures in the Pathogenesis of Experimental Diabetic Kidney Disease.
    Diao M; Wu Y; Yang J; Liu C; Xu J; Jin H; Wang J; Zhang J; Gao F; Jin C; Tian H; Xu J; Ou Q; Li Y; Xu G; Lu L
    Front Endocrinol (Lausanne); 2022; 13():843721. PubMed ID: 35432190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of hub genes in diabetic kidney disease via multiple-microarray analysis.
    Zhang Y; Li W; Zhou Y
    Ann Transl Med; 2020 Aug; 8(16):997. PubMed ID: 32953797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
    Chen S; Chen L; Jiang H
    Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell RNA and transcriptome sequencing profiles identify immune-associated key genes in the development of diabetic kidney disease.
    Zhang X; Chao P; Zhang L; Xu L; Cui X; Wang S; Wusiman M; Jiang H; Lu C
    Front Immunol; 2023; 14():1030198. PubMed ID: 37063851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of key genes and pathways in diabetic nephropathy by bioinformatics analysis.
    Geng XD; Wang WW; Feng Z; Liu R; Cheng XL; Shen WJ; Dong ZY; Cai GY; Chen XM; Hong Q; Wu D
    J Diabetes Investig; 2019 Jul; 10(4):972-984. PubMed ID: 30536626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of VCAN as Hub Gene for Diabetic Kidney Disease Immune Injury Using Integrated Bioinformatics Analysis.
    Xu Q; Li B; Wang Y; Wang C; Feng S; Xue L; Chen J; Jiang H
    Front Physiol; 2021; 12():651690. PubMed ID: 34557107
    [No Abstract]   [Full Text] [Related]  

  • 16. Identification of C3 as a therapeutic target for diabetic nephropathy by bioinformatics analysis.
    Tang S; Wang X; Deng T; Ge H; Xiao X
    Sci Rep; 2020 Aug; 10(1):13468. PubMed ID: 32778679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.
    Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
    BMC Endocr Disord; 2021 Apr; 21(1):80. PubMed ID: 33902539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioinformatic analysis of immune-related transcription factors in diabetic kidney disease].
    Liu L; Yang J; Ren J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Jun; 40(6):488-493. PubMed ID: 38952087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis and NETotic cell death affect diabetic nephropathy independently: An study integrative study encompassing bioinformatics, machine learning, and experimental validation.
    Cai H; Zeng Y; Luo D; Shao Y; Liu M; Wu J; Gao X; Zheng J; Zhou L; Liu F
    Genomics; 2024 Jul; 116(4):110879. PubMed ID: 38851464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.